The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon
Abstract
Objective: To document disease activity and functional status in patients with scleroderma (systemic sclerosis [SSc]) and Raynaud's phenomenon (RP) and to determine the sensitivity to change, reliability, ease of use, and validity of various outcome measures in these patients. Methods: Patients with SSc and moderate‐to‐severe RP participating in a multicenter RP treatment trial completed daily diaries documenting the frequency and duration of RP attacks and recorded a daily Raynaud's Condition Score (RCS). Mean scores for the 2‐week periods prior to baseline (week 0), end of trial (week 6), and posttrial followup (week 12) were calculated. At weeks 0, 6, and 12, physicians completed 3 global assessment scales and performed clinical assessments of digital ulcers and infarcts; patients completed the Health Assessment Questionnaire (HAQ), the Arthritis Impact Measurement Scales 2 (AIMS2) mood and tension subscales, 5 specific SSc/RP‐related visual analog scales (VAS), and 3 other VAS global assessments. We used these measures to document baseline disease activity and to assess their construct validity, sensitivity to change, and reliability in trial data. Results: Two hundred eighty‐one patients (248 women, 33 men; mean age 50.4 years [range 18–82 years]) from 14 centers participated. Forty‐eight percent had limited cutaneous SSc; 52% had diffuse cutaneous SSc. Fifty‐nine patients (21%) had digital ulcers at baseline. Patients had 3.89 ± 2.33 (mean ± SD) daily RP attacks (range 0.8–14.6), with a duration of 82.1 ± 91.6 minutes/attack. RCS for RP activity (possible range 0–10) was 4.30 ± 1.92. HAQ scores (0–3 scale) indicated substantial disability at baseline (total disability 0.86, pain 1.19), especially among the subscales pertaining to hand function (grip, eating, dressing). AIMS2 mood and tension scores were fairly high, as were many of the VAS scores. Patients with digital ulcers had worse RCS, pain, HAQ disability (overall, grip, eating, and dressing), physician's global assessment, and tension, but no significant difference in the frequency of RP, duration of RP, patient's global assessment, or mood, compared with patients without digital ulcers. VAS scores for digital ulcers as rated by the patients were not consistent with the physician's ratings. Factor analysis of the 18 measures showed strong associations among variables in 4 distinct domains: disease activity, RP measures, digital ulcer measures, and mood/tension. Reliability of the RCS, HAQ pain and disability scales, and AIMS2 mood and tension subscales was high. The RP measures demonstrated good sensitivity to change (effect sizes 0.33–0.76). Conclusion: Our findings demonstrate that the significant activity, disability, pain, and psychological impact of RP and digital ulcers in SSc can be measured by a small set of valid and reliable outcome measures. These outcome measures provide information beyond the quantitative metrics of RP attacks. We propose a core set of measures for use in clinical trials of RP in SSc patients that includes the RCS, patient and physician VAS ratings of RP activity, a digital ulcer/infarct measure, measures of disability and pain (HAQ), and measures of psychological function (AIMS2).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
Martin Bland, J., & Altman, D. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90837-8 · Cited by 47,965
(1965) · The Lancet · doi:10.1016/s0140-6736(65)91037-8 · Cited by 16,856
Applied Regression Analysis and Other Multivariable Methods
Walker, E. (1989) · Technometrics · doi:10.1080/00401706.1989.10488486 · Cited by 8,538
Preliminary criteria for the classification of systemic sclerosis (scleroderma)
Masi, A. T., & Subcommittee For Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) · Arthritis & Rheumatism · doi:10.1002/art.1780230510 · Cited by 4,898
Measurement of patient outcome in arthritis
Fries, J. F., Spitz, P., Kraines, R. G., & Holman, H. R. (1980) · Arthritis & Rheumatism · doi:10.1002/art.1780230202 · Cited by 4,382
Factor Analysis: Statistical Methods and Practical Issues
Kim, J.-O., & Mueller, C. W. (1978) · Cited by 2,778
Effect Sizes for Interpreting Changes in Health Status
Kazis, L. E., Anderson, J. J., & Meenan, R. F. (1989) · Medical Care · doi:10.1097/00005650-198903001-00015 · Cited by 2,401
Self-citationApplied Regression Analysis and Other Multivariable Methods.
Bhattacharyya, H. T., Kleinbaum, D. G., & Kupper, L. L. (1979) · Journal of the American Statistical Association · doi:10.2307/2287012 · Cited by 1,749
The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales.
Fries, J. F., Spitz, P. W., & Young, D. Y. (1982) · PubMed · Cited by 1,318
Measuring health status in arthritis
Meenan, R. F., Gertman, P. M., & Mason, J. H. (1980) · Arthritis & Rheumatism · doi:10.1002/art.1780230203 · Cited by 1,176
Cited by
Korn, J. H., Mayes, M., Matucci Cerinic, M., Rainisio, M., Pope, J., Hachulla, E., Rich, E., Carpentier, P., Molitor, J., Seibold, J. R., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20676 · Cited by 728
Self-citationMatucci-Cerinic, M., Denton, C. P., Furst, D. E., Mayes, M. D., Hsu, V. M., Carpentier, P., Wigley, F. M., Black, C. M., Fessler, B. J., Merkel, P. A., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.130658 · Cited by 498
Self-citationDenton (2007) · doi:10.1002/art.22289 · Cited by 447
Sildenafil in the Treatment of Raynaud’s Phenomenon Resistant to Vasodilatory Therapy
Fries, R., Shariat, K., von Wilmowsky, H., & Böhm, M. (2005) · Circulation · doi:10.1161/circulationaha.104.523324 · Cited by 337
T cell polarization identifies distinct clinical phenotypes in scleroderma lung disease
Boin, F., De Fanis, U., Bartlett, S. J., Wigley, F. M., Rosen, A., & Casolaro, V. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23406 · Cited by 81
Self-citation
Metadata
- Authors
- Merkel, P. A., Herlyn, K., Martin, R. W., Anderson, J. J., Mayes, M. D., Bell, P., Korn, J. H., Simms, R. W., Csuka, M. E., Medsger, T. A., Rothfield, N. F., Ellman, M. H., Collier, D. H., Weinstein, A., Furst, D. E., Jiménez, S. A., White, B., Seibold, J. R., Wigley, F. M., & for the Scleroderma Clinical Trials Consortium
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2002-09
- Volume
- 46
- Issue
- 9
- Pages
- 2410-2420
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2054504088
- Cited by
- 336
- References
- 25
- FWCI
- 4.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.